Suppr超能文献

肝硬化中的胆结石疾病——发病机制与管理

Gallstone Disease in Cirrhosis-Pathogenesis and Management.

作者信息

Mallick Bipadabhanjan, Anand Anil C

机构信息

Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India.

出版信息

J Clin Exp Hepatol. 2022 Mar-Apr;12(2):551-559. doi: 10.1016/j.jceh.2021.09.011. Epub 2021 Sep 16.

Abstract

Gallstones are more common in patients with cirrhosis of the liver, and the incidence increases with severity of liver disease. Pigment stones are the most frequent type of gallstones (GSs) in cirrhotics, and majority remain asymptomatic. Hepatitis C virus infection and nonalcoholic fatty liver disease are the underlying etiologies of liver diseases that most often associated with GSs. Multiple altered mechanisms in cirrhosis such as chronic hemolysis due to hypersplenism, reduced bile acid synthesis and transport, decreased cholesterol secretion, decreased apolipoprotein A-I and A-II secretion, gallbladder hypo-motility, autonomic dysfunction, and portal hypertension collectively lead to increased risk of lithogenesis. Asymptomatic GSs should be followed up closely and offered laparoscopic cholecystectomy once symptomatic in Child-Pugh class A and B patients. The model for the end-stage liver disease score is the best predictor of the outcome after cholecystectomy. In patients of Child-Pugh class C, conservative or minimally invasive approaches should be used to treat complications of GSs.

摘要

胆结石在肝硬化患者中更为常见,且发病率随肝病严重程度的增加而上升。色素结石是肝硬化患者中最常见的胆结石类型,大多数患者无症状。丙型肝炎病毒感染和非酒精性脂肪性肝病是最常与胆结石相关的肝病潜在病因。肝硬化中的多种机制改变,如脾功能亢进导致的慢性溶血、胆汁酸合成和转运减少、胆固醇分泌减少、载脂蛋白A-I和A-II分泌减少、胆囊运动功能减退、自主神经功能障碍以及门静脉高压,共同导致结石形成风险增加。对于无症状的胆结石,应密切随访,一旦Child-Pugh A级和B级患者出现症状,应进行腹腔镜胆囊切除术。终末期肝病模型评分是胆囊切除术后预后的最佳预测指标。对于Child-Pugh C级患者,应采用保守或微创方法治疗胆结石并发症。

相似文献

1
Gallstone Disease in Cirrhosis-Pathogenesis and Management.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):551-559. doi: 10.1016/j.jceh.2021.09.011. Epub 2021 Sep 16.
2
Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.
World J Gastroenterol. 2014 Jun 21;20(23):7277-85. doi: 10.3748/wjg.v20.i23.7277.
3
Cholelithiasis and cholecystitis.
J Long Term Eff Med Implants. 2005;15(3):329-38. doi: 10.1615/jlongtermeffmedimplants.v15.i3.90.

引用本文的文献

4
Physical activity and risk of cholelithiasis: a narrative review.
Front Med (Lausanne). 2024 Dec 16;11:1485097. doi: 10.3389/fmed.2024.1485097. eCollection 2024.
5
Associations of gallbladder and gallstone parameters with clinical outcomes in patients with cirrhosis.
J Transl Int Med. 2023 Mar 19;12(3):308-316. doi: 10.2478/jtim-2022-0076. eCollection 2024 Jun.
6
Identification of Intestinal Microbial Community in Gallstone Patients with Metagenomic Next-Generation Sequencing.
Diagnostics (Basel). 2023 Aug 21;13(16):2712. doi: 10.3390/diagnostics13162712.
8
Surgical Risk Assessment in Patients with Chronic Liver Diseases.
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1175-1183. doi: 10.1016/j.jceh.2022.03.004. Epub 2022 Mar 23.

本文引用的文献

1
Laparoscopic cholecystectomy in patients with liver cirrhosis: 8 years experience in a tertiary center. A retrospective cohort study.
Ann Med Surg (Lond). 2020 Jan 15;51:1-10. doi: 10.1016/j.amsu.2020.01.003. eCollection 2020 Mar.
2
EUS-guided gallbladder drainage in patients with cirrhosis: results of a multicenter retrospective study.
Endosc Int Open. 2019 Sep;7(9):E1099-E1104. doi: 10.1055/a-0965-6662. Epub 2019 Aug 29.
4
Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events.
World J Gastrointest Endosc. 2018 Nov 16;10(11):354-366. doi: 10.4253/wjge.v10.i11.354.
7
Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.
Turk J Gastroenterol. 2017 Jan;28(1):31-39. doi: 10.5152/tjg.2016.0357. Epub 2016 Dec 19.
8
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.
J Hepatol. 2016 Jul;65(1):146-181. doi: 10.1016/j.jhep.2016.03.005. Epub 2016 Apr 13.
9
Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Dig Dis Sci. 2016 Aug;61(8):2389-2396. doi: 10.1007/s10620-016-4125-2. Epub 2016 Mar 18.
10
Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
Liver Int. 2016 Oct;36(10):1457-63. doi: 10.1111/liv.13100. Epub 2016 Mar 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验